heecap

Heecap is a medical technology company founded in 2020 by Sofía Ferreira and Laura Lizama. The company focuses on enhancing patient outcomes in critical care by addressing respiratory muscle atrophy in patients on mechanical ventilation in intensive care units (ICUs). Heecap develops a non-invasive, personalized electrostimulation system designed to maintain and strengthen respiratory muscles, particularly the diaphragm, in these patients. The core product is an innovative medical device that aims to prevent respiratory muscle atrophy, a serious complication for ICU patients. By stimulating respiratory muscles, Heecap’s system supports faster recovery and enhances respiratory autonomy, potentially reducing the duration of mechanical ventilation and improving overall patient quality of life. The technology is currently undergoing clinical trials in leading hospitals in Spain, with the goal of validating its safety and efficacy. Heecap has secured funding to support these trials and is working towards CE mark certification for commercial distribution in Europe. The primary customers are hospitals and healthcare providers specializing in critical care.

• Employees 9
• Founded 2021